Eleven Biotherapeutics creates novel and differentiated biotherapeutics: first-of-a-kind protein-based drugs with significantly improved physical, pharmaceutical, and therapeutic benefits.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/08/12 | $20,000,000 | Series A |
Icon Ventures | undisclosed |
